These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38892519)

  • 1. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels.
    Fogacci F; Giovannini M; Di Micoli A; Fiorini G; Grandi E; Borghi C; Cicero AFG
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dietary Supplementation with Eufortyn
    Fogacci F; Rizzoli E; Giovannini M; Bove M; D'Addato S; Borghi C; Cicero AFG
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects.
    Cicero AFG; Fogacci F; Bove M; Giovannini M; Borghi C
    Phytother Res; 2019 Aug; 33(8):2094-2101. PubMed ID: 31225673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial.
    Fogacci F; Giovannini M; Imbalzano E; Grandi E; Rizzoli E; D'Addato S; Cicero AFG
    Arch Med Sci; 2023; 19(5):1228-1235. PubMed ID: 37732063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.
    Ogier N; Amiot MJ; Georgé S; Maillot M; Mallmann C; Maraninchi M; Morange S; Lescuyer JF; Peltier SL; Cardinault N
    Eur J Nutr; 2013 Mar; 52(2):547-57. PubMed ID: 22527287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus
    Cicero AFG; Fogacci F; Tocci G; D'Addato S; Grandi E; Banach M; Borghi C
    Arch Med Sci; 2023; 19(5):1169-1179. PubMed ID: 37732047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
    Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
    Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial.
    Panahi Y; Kianpour P; Mohtashami R; Atkin SL; Butler AE; Jafari R; Badeli R; Sahebkar A
    Phytother Res; 2018 Jul; 32(7):1382-1387. PubMed ID: 29520889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study.
    Barrat E; Zaïr Y; Sirvent P; Chauveau P; Maudet C; Housez B; Derbord E; Lescuyer JF; Bard JM; Cazaubiel M; Peltier SL
    Eur J Nutr; 2013 Dec; 52(8):1843-52. PubMed ID: 23266743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.
    Barrat E; Zaïr Y; Ogier N; Housez B; Vergara C; Maudet C; Lescuyer JF; Bard JM; Carpentier YA; Cazaubiel M; Peltier SL
    Int J Food Sci Nutr; 2013 Nov; 64(7):882-9. PubMed ID: 23815518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial.
    Fogacci F; Di Micoli V; Veronesi M; Cicero AFG
    Arch Med Sci; 2023; 19(5):1180-1185. PubMed ID: 37732027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled trial of a proprietary lipid-lowering nutraceutical supplement in the management of dyslipidemia.
    Houston M; Rountree R; Lamb J; Phipps S; Meng S; Zhang B
    J Biol Regul Homeost Agents; 2016; 30(4):1115-1123. PubMed ID: 28078862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers.
    Sharifi N; Amani R; Hajiani E; Cheraghian B
    Exp Biol Med (Maywood); 2016 Apr; 241(8):830-8. PubMed ID: 26811103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial.
    Rondanelli M; Giacosa A; Opizzi A; Faliva MA; Sala P; Perna S; Riva A; Morazzoni P; Bombardelli E
    Int J Food Sci Nutr; 2013 Feb; 64(1):7-15. PubMed ID: 22746542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
    Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.